Ideaya Biosciences
Price & Volume
Stats
See more52W Range | $13.45-$39.28 |
Market Cap | $3.1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $214.8M |
Revenue Growth (YoY) | 78.5% |
Gross Profit (12 Mos) | -$153.4M |
Diluted EPS | -$1.89 |
News
See moreYahoo Finance • last month
Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers
Yahoo Finance • last month
IDEAYA Biosciences Completes Targeted Full Enrollment in Randomized Pivotal Phase 2/3 Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in First-line HLA*A2-Negative Metastatic Uveal Melanoma
Yahoo Finance • 2 months ago
IDEAYA Secures IND Clearance For IDE034 In Solid Tumors
Yahoo Finance • 2 months ago
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Mr. Yujiro S. Hata |
Address | 5000 Shoreline Court, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
